Regeneron Pharmaceuticals
REGN
REGN
637 hedge funds and large institutions have $26.9B invested in Regeneron Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 111 funds opening new positions, 238 increasing their positions, 200 reducing their positions, and 71 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
637
Holders Change
+33
Holders Change %
+5.46%
% of All Funds
14.47%
Holding in Top 10
11
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-31.25%
% of All Funds
0.25%
New
111
Increased
238
Reduced
200
Closed
71
Calls
$1.23B
Puts
$1.26B
Net Calls
-$37.5M
Net Calls Change
+$233M
Top Buyers
| 1 |
Renaissance Technologies
New York
|
$218M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
$181M |
| 3 |
D.E. Shaw & Co
New York
|
$201M |
| 4 |
Two Sigma Advisers
New York
|
$143M |
| 5 |
Two Sigma Investments
New York
|
$129M |
